Sullivan C E, Issa F G, Berthon-Jones M, McCauley V B, Costas L J
Bull Eur Physiopathol Respir. 1984 Jan-Feb;20(1):49-54.
Continuous positive airway pressure (CPAP) applied through the nose completely prevented obstructive apnoea during all night testing in 50 patients with severe obstructive apnoea. In early 1981, we began a home treatment trial of nasal CPAP. Patients were treated in hospital for 3 to 5 nights, a period in which they were trained to fit the custom made nose-mask used to provide nasal CPAP. Patients subsequently continued treatment at home. Daytime somnolence resolved within days of starting therapy, and did not recur while the nasal CPAP unit was used on a regular basis. At present, we have 35 patients who have been on therapy for periods ranging between 3 and 30 months. Although each patient has displayed a reduction of severity of the underlying sleep apnoea when tested without nasal CPAP, the majority continue to require regular nightly nasal CPAP. In a few patients, treatment with nasal CPAP appeared to help in weight control such that obstructive apnoea and snoring have resolved. Nasal CPAP is a safe, fully effective therapy for obstructive apnoea, and can be used indefinitely by the patient at home.
通过鼻腔施加持续气道正压通气(CPAP),在对50例重度阻塞性睡眠呼吸暂停患者进行的整夜测试中,完全防止了阻塞性呼吸暂停。1981年初,我们开始了一项鼻腔CPAP家庭治疗试验。患者在医院接受3至5个晚上的治疗,在此期间他们接受培训,以佩戴用于提供鼻腔CPAP的定制鼻罩。患者随后在家中继续治疗。白天嗜睡在开始治疗后的几天内就得到缓解,并且在定期使用鼻腔CPAP装置期间不再复发。目前,我们有35例患者接受治疗的时间在3至30个月之间。尽管在不使用鼻腔CPAP进行测试时,每个患者潜在的睡眠呼吸暂停严重程度都有所降低,但大多数患者仍需要每晚定期使用鼻腔CPAP。在少数患者中,鼻腔CPAP治疗似乎有助于控制体重,从而使阻塞性呼吸暂停和打鼾得到缓解。鼻腔CPAP是一种治疗阻塞性呼吸暂停的安全、完全有效的疗法,患者可以在家中无限期使用。